Octinib Tab (5.4 mg / 16 mg) – Oclacitinib for Dogs | Allergy & Itch Relief

Octinib Tab – Veterinary JAK Inhibitor for Canine Allergy & Itch Relief

Octinib Tab contains Oclacitinib Maleate, a selective Janus Kinase (JAK) inhibitor formulated for dogs. Available in 5.4 mg and 16 mg strengths, it provides rapid and effective relief from allergic itching and inflammation associated with atopic and allergic dermatitis. By targeting cytokine pathways, it controls pruritus within hours and supports long-term skin health in canines over 12 months of age.

Key Benefits

• Fast Itch Relief: Begins working within 4–24 hours, breaking the itch-scratch cycle quickly.
• Anti-Inflammatory Action: Reduces redness, inflammation, and risk of secondary skin infections.
• Long-Term Management: Suitable for maintenance therapy following the initial loading dose period.
• Easy Administration: Palatable oral tablet — can be given with or without food for stress-free dosing.

Composition

Each tablet contains: Oclacitinib Maleate — available in 5.4 mg and 16 mg strengths.

Indications

• Control of pruritus (itching) due to allergic dermatitis
• Atopic dermatitis in dogs
• Flea allergy dermatitis
• Food and contact allergies in dogs

Directions for Use

Initial Phase: 0.4–0.6 mg/kg body weight twice daily for up to 14 days.

Maintenance Phase: 0.4–0.6 mg/kg body weight once daily.

Administer orally with or without food. Veterinary monitoring is required during therapy. Avoid use in breeding, pregnant, or lactating dogs. For use in dogs over 12 months of age only.

Disclosure

A licensed vendor partner will deliver this medicine to you. Once the pharmacy accepts your order, the pharmacy details will be shared with you. Acceptance of your order is based on the validity of your doctor's prescription and the availability of the medicine.